-$87M
Value of Insider Transactions in the last 2 years

Sign up to access historical data

Sign up

Insider Transactions

Name Transaction Date Sold / Bought Shares Price Value
Dunlop A. SinclairSep 16, 2024Sell29,476$36.09$1.1M
Dunlop A. SinclairSep 16, 2024Sell7,524$36.79$280,000
Chopas James GeorgeSep 16, 2024Sell192$36.206$7,000
Chopas James GeorgeSep 3, 2024Sell550$39.491$22,000
Dunlop A. SinclairJun 21, 2024Sell35,305$39.22$1.4M
Dunlop A. SinclairJun 21, 2024Sell1,695$39.63$67,000
Deschatelets PascalMay 8, 2024Sell56,335$42.1504$2.4M
Deschatelets PascalMay 8, 2024Sell22,472$42.849$960,000
Deschatelets PascalMay 8, 2024Sell100$44.025$4,400
Deschatelets PascalApr 8, 2024Sell64,379$54.1165$3.5M
Deschatelets PascalApr 8, 2024Sell4,728$54.9152$260,000
Sullivan Timothy EugeneApr 1, 2024Sell4,000$58.66$230,000
Dunlop A. SinclairMar 19, 2024Sell18,681$57.179$1.1M
DeLong Mark JeffreyMar 18, 2024Sell9,913$56.9$560,000
Chopas James GeorgeMar 15, 2024Sell184$56.461$10,000
Nicholson NurMar 13, 2024Sell7,768$57.307$450,000
Nicholson NurMar 13, 2024Sell3,452$58.1335$200,000
Deschatelets PascalMar 8, 2024Sell42,750$61.8754$2.6M
Deschatelets PascalMar 8, 2024Sell26,257$62.6896$1.6M
Deschatelets PascalMar 8, 2024Sell100$63.35$6,300
Francois CedricMar 1, 2024Sell116,512$64.9163$7.6M
Francois CedricMar 1, 2024Sell62,503$64.2573$4M
Francois CedricMar 1, 2024Sell41,704$62.9631$2.6M
Francois CedricMar 1, 2024Sell28,868$62.213$1.8M
Sullivan Timothy EugeneMar 1, 2024Sell4,000$62.86$250,000
Sullivan Timothy EugeneMar 1, 2024Sell2,000$63.95$130,000
Francois CedricMar 1, 2024Sell413$65.68$27,000
Lewis KarenJan 30, 2024Sell883$65.53$58,000
Eisele JeffreyJan 30, 2024Sell971$65.53$64,000
Francois CedricJan 29, 2024Sell2,843$64.1382$180,000
Watson David O.Jan 29, 2024Sell906$64.1382$58,000
Townsend Adam J.Jan 29, 2024Sell906$64.1382$58,000
Sullivan Timothy EugeneJan 29, 2024Sell906$64.1382$58,000
Nicholson NurJan 29, 2024Sell835$64.1382$54,000
Lewis KarenJan 29, 2024Sell367$64.1382$24,000
Eisele JeffreyJan 29, 2024Sell279$64.1382$18,000
Deschatelets PascalJan 29, 2024Sell874$64.1382$56,000
DeLong Mark JeffreyJan 29, 2024Sell367$64.1382$24,000
Lewis KarenJan 23, 2024Sell4,286$63.69$270,000
Eisele JeffreyJan 23, 2024Sell7,378$63.69$470,000
Francois CedricJan 22, 2024Sell13,431$64.996$870,000
Watson David O.Jan 22, 2024Sell4,184$64.996$270,000
Townsend Adam J.Jan 22, 2024Sell3,413$64.996$220,000
Sullivan Timothy EugeneJan 22, 2024Sell3,551$64.996$230,000
Nicholson NurJan 22, 2024Sell2,593$64.996$170,000
Lewis KarenJan 22, 2024Sell1,738$64.996$110,000
Eisele JeffreyJan 22, 2024Sell1,607$64.996$100,000
Deschatelets PascalJan 22, 2024Sell3,913$64.996$250,000
DeLong Mark JeffreyJan 22, 2024Sell1,384$64.996$90,000
Chopas James GeorgeJan 22, 2024Sell1,061$64.996$69,000
Eisele JeffreyJan 17, 2024Sell5,207$65.58$340,000
Lewis KarenJan 17, 2024Sell3,276$65.58$210,000
Deschatelets PascalJan 16, 2024Sell1,632$66.8086$110,000
Lewis KarenJan 16, 2024Sell1,632$66.8086$110,000
DeLong Mark JeffreyJan 16, 2024Sell1,631$66.8086$110,000
Nicholson NurJan 16, 2024Sell1,857$66.8086$120,000
Watson David O.Jan 16, 2024Sell4,240$66.8086$280,000
Townsend Adam J.Jan 16, 2024Sell2,235$66.8086$150,000
Sullivan Timothy EugeneJan 16, 2024Sell2,235$66.8086$150,000
Francois CedricJan 16, 2024Sell7,851$66.8086$520,000
Chopas James GeorgeJan 16, 2024Sell864$66.8086$58,000
Eisele JeffreyJan 16, 2024Sell438$66.8086$29,000
Baumal CarolineJan 4, 2024Sell2,751$60.0534$170,000
Eisele JeffreyDec 27, 2023Sell235$60.23$14,000
Eisele JeffreyDec 26, 2023Sell68$57.8609$3,900
Watson David O.Dec 19, 2023Sell2,300$57.3827$130,000
Watson David O.Dec 19, 2023Sell1,605$57.0041$91,000
SCHEIBLER LUKASDec 1, 2023Sell10,000$60$600,000
Townsend Adam J.Dec 1, 2023Sell67,557$60.5019$4.1M
Townsend Adam J.Dec 1, 2023Sell42,443$61.3052$2.6M
Dunlop A. SinclairDec 1, 2023Sell24,000$61.135$1.5M
Sullivan Timothy EugeneNov 30, 2023Sell13,858$54.73$760,000
Sullivan Timothy EugeneNov 30, 2023Sell300$54.7866$16,000
Francois CedricNov 21, 2023Sell5,000$48.8$240,000
Dunlop A. SinclairNov 17, 2023Sell8,894$49.991$440,000
Machiels AlecNov 17, 2023Sell1,250$47.74$60,000
Deschatelets PascalNov 8, 2023Sell12,000$47.27$570,000
Chopas James GeorgeOct 23, 2023Sell132$46.0362$6,100
DeLong Mark JeffreyOct 23, 2023Sell131$46.0362$6,000
Dunlop A. SinclairOct 17, 2023Sell24,000$49$1.2M
Machiels AlecOct 17, 2023Sell1,250$48.5$61,000
Deschatelets PascalOct 9, 2023Sell12,000$40.38$480,000
Nicholson NurSep 18, 2023Sell10,631$46.147$490,000
Machiels AlecSep 18, 2023Sell1,250$45$56,000
Nicholson NurSep 18, 2023Sell9,719$42.2085$410,000
Machiels AlecSep 15, 2023Sell1,250$45.34$57,000
Deschatelets PascalSep 8, 2023Sell12,000$42.87$510,000
SCHEIBLER LUKASSep 6, 2023Sell1,756$43.01$76,000
Francois CedricSep 1, 2023Sell139,716$41.7025$5.8M
Francois CedricSep 1, 2023Sell10,284$42.44$440,000
Chopas James GeorgeAug 31, 2023Sell551$41.226$23,000
Deschatelets PascalAug 8, 2023Sell12,000$23.66$280,000
Machiels AlecJul 17, 2023Sell1,250$64.79$81,000
Deschatelets PascalJul 10, 2023Sell12,000$84.55$1M
Watson David O.Jul 3, 2023Sell8,510$89.98$770,000
Sullivan Timothy EugeneJul 3, 2023Sell3,287$90.4165$300,000
Sullivan Timothy EugeneJul 3, 2023Sell3,192$89.4109$290,000
Sullivan Timothy EugeneJul 3, 2023Sell300$91.0983$27,000
Machiels AlecJun 20, 2023Sell1,250$88.41$110,000
Deschatelets PascalJun 8, 2023Sell12,000$91.35$1.1M
Sullivan Timothy EugeneJun 5, 2023Sell30,609$87.7886$2.7M
Sullivan Timothy EugeneJun 5, 2023Sell30,506$89.8259$2.7M
Sullivan Timothy EugeneJun 5, 2023Sell7,064$88.3649$620,000
Sullivan Timothy EugeneJun 5, 2023Sell1,600$90.6044$140,000
Lewis KarenJun 1, 2023Sell5,000$86$430,000
Machiels AlecMay 17, 2023Sell1,250$88.66$110,000
Francois CedricMay 16, 2023Sell14,611$85.0089$1.2M
Francois CedricMay 16, 2023Sell7,528$87.0163$660,000
Francois CedricMay 16, 2023Sell3,007$85.9012$260,000
Francois CedricMay 16, 2023Sell2,120$87.6739$190,000
Francois CedricMay 16, 2023Sell1,800$83.845$150,000
Francois CedricMay 16, 2023Sell934$83.1711$78,000
Deschatelets PascalMay 8, 2023Sell12,000$92.39$1.1M
Townsend Adam J.May 3, 2023Sell5,000$82.71$410,000
Francois CedricApr 18, 2023Sell30,000$82.024$2.5M
Machiels AlecApr 17, 2023Sell1,250$81.05$100,000
Deschatelets PascalApr 10, 2023Sell12,000$78.21$940,000
Lewis KarenApr 3, 2023Sell5,000$75$380,000
Townsend Adam J.Apr 3, 2023Sell5,000$74.05$370,000
Dunlop A. SinclairApr 3, 2023Sell500$74.05$37,000
Francois CedricMar 21, 2023Sell30,000$62.7444$1.9M
Machiels AlecMar 17, 2023Sell1,250$64.03$80,000
Deschatelets PascalMar 8, 2023Sell12,000$63.79$770,000
Townsend Adam J.Mar 3, 2023Sell5,000$63.84$320,000
Dunlop A. SinclairMar 1, 2023Sell500$65.33$33,000
Eisele JeffreyFeb 23, 2023Sell1,646$68.76$110,000
Lewis KarenFeb 23, 2023Sell1,104$68.76$76,000
Machiels AlecFeb 17, 2023Sell1,250$52.38$65,000
Deschatelets PascalFeb 8, 2023Sell12,000$54.45$650,000
Townsend Adam J.Feb 3, 2023Sell5,000$55.85$280,000
Dunlop A. SinclairFeb 1, 2023Sell500$52.61$26,000
Eisele JeffreyJan 30, 2023Sell883$52.76$47,000
Lewis KarenJan 30, 2023Sell883$52.76$47,000
Lewis KarenJan 23, 2023Sell2,955$51.58$150,000
Eisele JeffreyJan 23, 2023Sell4,479$51.58$230,000
Machiels AlecJan 17, 2023Sell1,250$52.42$66,000
Deschatelets PascalJan 9, 2023Sell12,000$46.08$550,000
Grossi FedericoJan 5, 2023Sell2,500$48.79$120,000
Townsend Adam J.Jan 3, 2023Sell5,000$50.7$250,000
Dunlop A. SinclairJan 3, 2023Sell500$50.7$25,000
Francois CedricDec 19, 2022Sell24,449$52.0697$1.3M
Francois CedricDec 19, 2022Sell3,751$51.9678$190,000
Machiels AlecDec 15, 2022Sell1,250$52.35$65,000
Deschatelets PascalDec 8, 2022Sell12,000$47.5$570,000
Townsend Adam J.Dec 5, 2022Sell5,000$50.38$250,000
Grossi FedericoDec 1, 2022Sell2,500$49.93$120,000
Dunlop A. SinclairDec 1, 2022Sell500$49.93$25,000

What's the latest insider transaction for Apellis Pharmaceuticals?

The most recent insider transaction for Apellis Pharmaceuticals was conducted by Dunlop A. Sinclair, who sold 29,476 shares on September 16, 2024 at a price of $36.09 per share.

Which insider has sold the most APLS stock over the last two years?

Francois Cedric has sold the most APLS stock in the last 2 years, with a total value of $32M.

What is the total value of insider transactions for Apellis Pharmaceuticals (APLS) in the last 2 years?

The total value of insider transactions for Apellis Pharmaceuticals in the last 2 years is negative, amounting to -$87M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

How do insider transactions over the last 2 years reflect on Apellis Pharmaceuticals' market confidence?

Over the last 2 years, insider transactions for Apellis Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.

Why is monitoring insider trading activity important for investors?

Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.